The US FDA recommends efficient clinical trial design strategies to expedite the development of oncology drugs and biologics. FDA also provides guidance and advice to sponsors of drugs and biologics for cancer treatment regarding the design and conduct of clinical trials, other than first-in-human (FIH) trials. In contrast to traditional trial designs, where a single […]

Read More →

Drug development is a lengthy, complex, and costly process, entrenched with a high degree of uncertainty that a drug will actually succeed and reach the market successfully. Drug development is the process of bringing a new pharmaceutical drug or a medical device or a treatment procedure to the market. Many developers often lack a clear […]

Read More →

South Korea is a well-reputed country with lots of years of clinical research to its credit. In fact, it has a long history of conducting global clinical trials than most other Asian countries including Japan. More than 80% of clinical trials conducted in South Korea are global, which is a great indicator of the suitability of […]

Read More →